{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T04:58:03Z","timestamp":1648789083564},"reference-count":16,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Exp Hematopathol","JCEH"],"published-print":{"date-parts":[[2011]]},"DOI":"10.3960\/jslrt.51.37","type":"journal-article","created":{"date-parts":[[2011,5,31]],"date-time":"2011-05-31T05:57:56Z","timestamp":1306821476000},"page":"37-42","source":"Crossref","is-referenced-by-count":2,"title":["A Highly Therapy-Resistant Case of B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma Showing Strong BCL2 Staining, Otherwise Indistinguishable from Burkitt Lymphoma"],"prefix":"10.3960","volume":"51","author":[{"given":"Naoki","family":"Kurita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Nishikii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzuru","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Okoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Suzukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhisa","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-02-0405"},{"issue":"24(Biological S","key":"2","first-page":"7824","volume":"79","year":"1982","ISSN":"http:\/\/id.crossref.org\/issn\/0027-8424","issn-type":"print"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Abramson J, Shipp M: Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach. Blood 106:1164-1174, 2005","DOI":"10.1182\/blood-2005-02-0687"},{"key":"4","unstructured":"4 Kluin PM, Rapha&euml;l M, Harris NL, Campo E, Stein H, <I>et al<\/I>. : B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, <I>et al<\/I>. (eds): World Health Organization Classification of Tumours, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed, International Agency for Research on Cancer (IARC), Lyon, pp. 265-266, 2008"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Greer W, Lee C, Callanan M, Zayed E, Sadek I: Case of acute lymphoblastic leukemia presenting with t(14;18)\/<I>BCL2<\/I>, t(8;14)\/<I>cMYC<\/I>, and t(1;2)\/<I>FCGR2B<\/I>. Am J Hematol 74:112-118, 2003","DOI":"10.1002\/ajh.10393"},{"key":"6","unstructured":"6 Divine M, Casassus P, Koscielny S, Bosq J, Sebban C, <I>et al<\/I>. : Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol. Ann Oncol 16:1928-1935, 2005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Grigg A, Seymour J: Graft versus Burkitt's lymphoma effect after allogeneic marrow transplantation. Leuk Lymphoma 43:889-892, 2002","DOI":"10.1080\/10428190290017051"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Ungkanont A, Mongkonsritrakoon W, Jootar S, Srichaikul T: Allogeneic stem cell transplantation in a patient with refractory Burkitt's lymphoma using non-myeloablative conditioning regimen. Bone Marrow Transplant 26:1351-1354, 2000","DOI":"10.1038\/sj.bmt.1702730"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Weinthal J, Goldman S, Lenarsky C: Successful treatment of relapsed Burkitt's lymphoma using unrelated cord blood transplantation as consolidation therapy. Bone Marrow Transplant 25:1311-1313, 2000","DOI":"10.1038\/sj.bmt.1702428"},{"key":"10","unstructured":"10 Johnson N, Savage K, Ludkovski O, Ben-Neriah S, Woods R, <I>et al<\/I>. : Lymphomas with concurrent <I>BCL2<\/I> and <I>MYC<\/I> translocations: the critical factors associated with survival. Blood 114:2273-2279, 2009"},{"key":"11","unstructured":"11 Evan G, Wyllie A, Gilbert C, Littlewood T, Land H, <I>et al<\/I>. : Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128, 1992"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M609138200"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M511914200"},{"key":"14","unstructured":"14 Tomita N, Tokunaka M, Nakamura N, Takeuchi K, Koike J, <I>et al<\/I>. : Clinicopathological features of lymphoma\/leukemia patients carrying both <I>BCL2<\/I> and <I>MYC<\/I> translocations. Haematologica 94:935-943, 2009"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Niitsu N, Okamoto M, Miura I, Hirano M: Clinical features and prognosis of <I>de novo<\/I> diffuse large B-cell lymphoma with t(14:18) and 8q24\/<I>c<\/I><I>-MYC<\/I> translocations. Leukemia 23:777-783, 2009","DOI":"10.1038\/leu.2008.344"},{"key":"16","unstructured":"16 Mead GM, Sydes MR, Walewski J, Grigg A, Hatton CS, <I>et al<\/I>. (UKLG LY06 collaborators): An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study. Ann Oncol 13:1264-1274, 2002"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T19:46:01Z","timestamp":1621539961000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jslrt\/51\/1\/51_1_37\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.51.37","relation":{},"ISSN":["1880-9952","1346-4280"],"issn-type":[{"value":"1880-9952","type":"electronic"},{"value":"1346-4280","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}